Clinical and genetic analyses reveal novel pathogenic ABCA4 mutations in Stargardt disease families

• DOI: 10.1038/srep35414
• Publication Date: 2016-10-14T10:20:31Z
• Authors: Bing Lin; Xue-Bi Cai; Zhi-Li Zheng; Xiu-Feng Huang; Xiao-Ling Liu; Jia Qu; Zi-Bing Jin
• Keywords: Adult; Male; 0303 health sciences; Middle Aged; Article; Pedigree; 3. Good health; Macular Degeneration; 03 medical and health sciences; Phenotype; Mutation; Humans; Stargardt Disease; ATP-Binding Cassette Transporters; Exome; Female; Child

AbstractStargardt disease (STGD1) is a juvenile macular degeneration predominantly inherited in an autosomal recessive pattern, characterized by decreased central vision in the first 2 decades of life. The condition has a genetic basis due to mutation in the ABCA4 gene, and arises from the deposition of lipofuscin-like substance in the retinal pigmented epithelium (RPE) with secondary photoreceptor cell death. In this study, we describe the clinical and genetic features of Stargardt patients from four unrelated Chinese cohorts. The targeted exome sequencing (TES) was carried out in four clinically confirmed patients and their family members using a gene panel comprising 164 known causative inherited retinal dystrophy (IRD) genes. Genetic analysis revealed eight ABCA4 mutations in all of the four pedigrees, including six mutations in coding exons and two mutations in adjacent intronic areas. All the affected individuals showed typical manifestations consistent with the disease phenotype. We disclose two novel ABCA4 mutations in Chinese patients with STGD disease, which will expand the existing spectrum of disease-causing variants and will further aid in the future mutation screening and genetic counseling, as well as in the understanding of phenotypic and genotypic correlations.